Literature DB >> 28961661

Blister Packaging Medication Increases Treatment Adherence in Psychiatric Patients.

Peter M Gutierrez1, Hal S Wortzel, Jeri E Forster, Rebecca A Leitner, Trisha A Hostetter, Lisa A Brenner.   

Abstract

OBJECTIVE: To evaluate whether blister packing medications would improve prescription medication adherence in psychiatric patients. It was hypothesized that patients in the blister pack (BP) condition would be more adherent to their daily medications than those in the dispense as usual condition.
METHODS: This was a randomized trial involving up to 1 year of monthly follow-up assessments. Participants were recruited from an urban Veterans Affairs (VA) Medical Center in the Western United States. Inclusion criteria for participants included being diagnosed with a major affective disorder, posttraumatic stress disorder, schizophrenia, or a combination of these disorders; being 18 to 89 years of age; receiving prescription medications from the VA pharmacy; and being considered competent to manage their own medications. Of the 303 patients who consented to participate, 277 were randomized to 1 of the 2 study conditions, and 243 were retained in the study. The sample was 87% male, 47% white, with a mean age of 54.4 years. All medications prescribed and dispensed by the VA were either repackaged in monthly BPs or dispensed in standard pill vials.
RESULTS: The primary hypothesis was supported. Patients in the BPs condition showed evidence of better adherence at 12-month follow-up, as well as larger increases in adherence from 1 month to 12 months.
CONCLUSIONS: Psychiatric patients adhere better to prescription medication regimens when receiving their medications in BP.

Entities:  

Mesh:

Year:  2017        PMID: 28961661     DOI: 10.1097/PRA.0000000000000252

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN: 1527-4160            Impact factor:   1.325


  2 in total

1.  Hummingbird Study: a study protocol for a multicentre exploratory trial to assess the acceptance and performance of a digital medicine system in adults with schizophrenia, schizoaffective disorder or first-episode psychosis.

Authors:  J Corey Fowler; Nathan Cope; Jonathan Knights; Peter Phiri; Andrew Makin; Tim Peters-Strickland; Shanaya Rathod
Journal:  BMJ Open       Date:  2019-06-27       Impact factor: 2.692

2.  Does Antiretroviral Therapy Packaging Matter? Perceptions and Preferences of Antiretroviral Therapy Packaging for People Living with HIV in Northern Tanzania.

Authors:  Charles Muiruri; Shelley A Jazowski; Seleman K Semvua; Francis P Karia; Brandon A Knettel; Leah L Zullig; Habib O Ramadhani; Blandina T Mmbaga; John A Bartlett; Hayden B Bosworth
Journal:  Patient Prefer Adherence       Date:  2020-01-23       Impact factor: 2.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.